Buspar and Tekturna drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Buspar (buspirone hydrochloride) and Tekturna (aliskiren hemifumarate). Common drug interactions include international normalised ratio decreased among females and fall among males.

The phase IV clinical study analyzes what interactions people have when they take Buspar and Tekturna. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.

What is Buspar?

Buspar has active ingredients of buspirone hydrochloride. It is often used in stress and anxiety. eHealthMe is studying from 20,462 Buspar users. Check the latest studies of Buspar.

What is Tekturna?

Tekturna has active ingredients of aliskiren hemifumarate. It is often used in high blood pressure. eHealthMe is studying from 4,730 Tekturna users. Check the latest studies of Tekturna.

On Jul, 12, 2026

12 people who take Buspar and Tekturna together, and have interactions are studied.

What are the common drug interactions of Buspar and Tekturna, by gender? *:

female:

International normalised ratio decreased
Palpitations (feelings or sensations that your heart is pounding or racing)
Transient ischaemic attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow))
Blood disorder
Bundle branch block left (absence of transmission of electric impulses from the atrioventricular (av) bundle of his to the left ventricle)
Chest pain
Fatigue (feeling of tiredness)
Application site erythema (redness of the skin at application site)
Application site pain
Application site rash

male:

Fall
Sudden death
Postoperative wound complication
Asthenia (weakness)
Blood creatinine increased
Fatigue (feeling of tiredness)
Acute prerenal failure (prerenal acute renal failure (arf) occurs when a sudden reduction in blood flow to the kidney)
Chest pain
Dizziness
Headache (pain in head)

What are the common drug interactions of Buspar and Tekturna, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Fall
Sudden death

50-59:

Application site erythema (redness of the skin at application site)
Application site pain
Application site rash
Application site swelling
Dizziness

60+:

Fatigue (feeling of tiredness)
Chest pain
Acute prerenal failure (prerenal acute renal failure (arf) occurs when a sudden reduction in blood flow to the kidney)
Coagulopathy (blood's ability to clot is impaired)
Dizziness
Hypoaesthesia facial (reduced sense of touch or sensation on face)
Hypovolaemia (a decreased volume of circulating blood in the body)
Postoperative wound complication
Sensory disturbance (sense disturbance)
Therapeutic response decreased (less preventive response)

What are the existing conditions these people have? *

Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 16.67%
Cardiomyopathy (weakening of the heart muscle): 2 people, 16.67%
Thyroid Diseases: 1 person, 8.33%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 1 person, 8.33%
Migraine (headache): 1 person, 8.33%
Glaucoma (increased fluid pressure in the eye with vision loss): 1 person, 8.33%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Buspar and Tekturna?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously